NO AXILLARY SURGERY IN EARLY BREAST CANCER (OXIGENATE)

ConditionBreast Cancer

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorClinica Universidad de Navarra, Universidad de Navarra

About this trial

Prospective study will establish a comprehensive international registry specifically for patients who have undergone surgery for primary breast cancer without SLNB. The main objective of this registry is to gather detailed, real-world data on the outcomes of this particular treatment approach, providing insights into the clinical efficacy and quality of life of patients when SLNB is omitted.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Early stage breast cancer patients with omission of SLN

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Omission SLN
Procedure/Surgery
Omission SLN

Treatment groups

827 Participants

are divided into 1 treatment group

Group A: Early stage breast cancer ptients with omission of sentinel node biopsy1 intervention

Trial outcomes

Primary outcomes

Axillary Recurrence

Determine the clinical efficacy of omitting a SLN i

Time frame

from enrollement to the end of follow up 5 years

3 year axillary recurrence

Identify if patients with no axillary surgery had an increased axillary recurrence

Time frame

3 years

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Clinica Universidad de Navarra, Universidad de Navarra

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: